Europe

Sep 07, 2016
Leela Barham reviews NHS England's proposals for the creation of Regional Medicines Optimization Committees.
Aug 15, 2016
Reflector outlines the obstacles ahead for Europe's revamped Innovative Medicines Initiative.
Aug 10, 2016
If managed access is to be a widely available option, it makes sense to re-assess just how much should be spent on it, writes Leela Barham.
Jul 29, 2016
A ‘new’ version of the English Cancer Drugs Fund (CDF) comes into force today. Leela Barham reports.
Jul 29, 2016
Paul Ranson examines how the UK biopharma must now adapt to a changing landscape.
Jul 27, 2016
Leela Barham looks at the EU plans for a European patent, and asks where the UK will fit in after Brexit.
Jul 20, 2016
Not yet, says Reflector. But to judge from the European Parliament's latest foray into the subject, there could be plenty of support for such an approach.
Jul 12, 2016
Pharmaceutical Executive
A look at how Europe’s new accelerated drug approval scheme can move existing review pathways to something better—and take a page from the FDA experience as well.
Jun 09, 2016
Radicals who wield real power at the EMA have gone public with their thinking about the role of regulators in the economic aspects of medicines provision.
Jun 01, 2016
Eleanor Biggs looks at the biggest uncertainties facing the pharma industry if the UK were to leave the EU.
native1_300x100
lorem ipsum